171 related articles for article (PubMed ID: 29718184)
1. The pyrin inflammasome: from sensing RhoA GTPases-inhibiting toxins to triggering autoinflammatory syndromes.
Jamilloux Y; Magnotti F; Belot A; Henry T
Pathog Dis; 2018 Apr; 76(3):. PubMed ID: 29718184
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis of intestinal epithelial cells restricts Clostridium difficile infection in a model of pseudomembranous colitis.
Saavedra PHV; Huang L; Ghazavi F; Kourula S; Vanden Berghe T; Takahashi N; Vandenabeele P; Lamkanfi M
Nat Commun; 2018 Nov; 9(1):4846. PubMed ID: 30451870
[TBL] [Abstract][Full Text] [Related]
3. The Yersinia pestis Effector YopM Inhibits Pyrin Inflammasome Activation.
Ratner D; Orning MP; Proulx MK; Wang D; Gavrilin MA; Wewers MD; Alnemri ES; Johnson PF; Lee B; Mecsas J; Kayagaki N; Goguen JD; Lien E
PLoS Pathog; 2016 Dec; 12(12):e1006035. PubMed ID: 27911947
[TBL] [Abstract][Full Text] [Related]
4. The pyrin inflammasome in host-microbe interactions.
Loeven NA; Medici NP; Bliska JB
Curr Opin Microbiol; 2020 Apr; 54():77-86. PubMed ID: 32120337
[TBL] [Abstract][Full Text] [Related]
5. The Pyrin Inflammasome in Health and Disease.
Schnappauf O; Chae JJ; Kastner DL; Aksentijevich I
Front Immunol; 2019; 10():1745. PubMed ID: 31456795
[TBL] [Abstract][Full Text] [Related]
6. Methods for Detection of Pyrin Inflammasome Assembly in Macrophages Infected with Yersinia spp.
Medici NP; Bliska JB
Methods Mol Biol; 2019; 2010():241-255. PubMed ID: 31177443
[TBL] [Abstract][Full Text] [Related]
7. Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome.
Xu H; Yang J; Gao W; Li L; Li P; Zhang L; Gong YN; Peng X; Xi JJ; Chen S; Wang F; Shao F
Nature; 2014 Sep; 513(7517):237-41. PubMed ID: 24919149
[TBL] [Abstract][Full Text] [Related]
8. The pyrin inflammasome and the Yersinia effector interaction.
Malik HS; Bliska JB
Immunol Rev; 2020 Sep; 297(1):96-107. PubMed ID: 32721043
[TBL] [Abstract][Full Text] [Related]
9. Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome.
Jamilloux Y; Lefeuvre L; Magnotti F; Martin A; Benezech S; Allatif O; Penel-Page M; Hentgen V; Sève P; Gerfaud-Valentin M; Duquesne A; Desjonquères M; Laurent A; Rémy-Piccolo V; Cimaz R; Cantarini L; Bourdonnay E; Walzer T; Py BF; Belot A; Henry T
Rheumatology (Oxford); 2018 Jan; 57(1):100-111. PubMed ID: 29040788
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Pyrin Dephosphorylation and Inflammasome Activation in Macrophages as Triggered by the
Medici NP; Rashid M; Bliska JB
Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30602502
[TBL] [Abstract][Full Text] [Related]
11. The Yersinia Virulence Factor YopM Hijacks Host Kinases to Inhibit Type III Effector-Triggered Activation of the Pyrin Inflammasome.
Chung LK; Park YH; Zheng Y; Brodsky IE; Hearing P; Kastner DL; Chae JJ; Bliska JB
Cell Host Microbe; 2016 Sep; 20(3):296-306. PubMed ID: 27569559
[TBL] [Abstract][Full Text] [Related]
12. Function and mechanism of the pyrin inflammasome.
Heilig R; Broz P
Eur J Immunol; 2018 Feb; 48(2):230-238. PubMed ID: 29148036
[TBL] [Abstract][Full Text] [Related]
13. RIPK3 Promotes
Sharma D; Malik A; Balakrishnan A; Malireddi RKS; Kanneganti TD
J Immunol; 2020 Nov; 205(10):2778-2785. PubMed ID: 32989095
[TBL] [Abstract][Full Text] [Related]
14. Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation.
Van Gorp H; Saavedra PH; de Vasconcelos NM; Van Opdenbosch N; Vande Walle L; Matusiak M; Prencipe G; Insalaco A; Van Hauwermeiren F; Demon D; Bogaert DJ; Dullaers M; De Baere E; Hochepied T; Dehoorne J; Vermaelen KY; Haerynck F; De Benedetti F; Lamkanfi M
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14384-14389. PubMed ID: 27911804
[TBL] [Abstract][Full Text] [Related]
15. The pyrin inflammasome, a leading actor in pediatric autoinflammatory diseases.
La Bella S; Di Ludovico A; Di Donato G; Basaran O; Ozen S; Gattorno M; Chiarelli F; Breda L
Front Immunol; 2023; 14():1341680. PubMed ID: 38250061
[TBL] [Abstract][Full Text] [Related]
16. Bacterial protein toxins inhibiting low-molecular-mass GTP-binding proteins.
Just I; Hofmann F; Genth H; Gerhard R
Int J Med Microbiol; 2001 Sep; 291(4):243-50. PubMed ID: 11680784
[TBL] [Abstract][Full Text] [Related]
17. The Relationship between NALP3 and Autoinflammatory Syndromes.
Campbell L; Raheem I; Malemud CJ; Askari AD
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187378
[TBL] [Abstract][Full Text] [Related]
18. Site-specific phosphorylation and microtubule dynamics control Pyrin inflammasome activation.
Gao W; Yang J; Liu W; Wang Y; Shao F
Proc Natl Acad Sci U S A; 2016 Aug; 113(33):E4857-66. PubMed ID: 27482109
[TBL] [Abstract][Full Text] [Related]
19. A Burkholderia Type VI Effector Deamidates Rho GTPases to Activate the Pyrin Inflammasome and Trigger Inflammation.
Aubert DF; Xu H; Yang J; Shi X; Gao W; Li L; Bisaro F; Chen S; Valvano MA; Shao F
Cell Host Microbe; 2016 May; 19(5):664-74. PubMed ID: 27133449
[TBL] [Abstract][Full Text] [Related]
20. Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS.
Park YH; Wood G; Kastner DL; Chae JJ
Nat Immunol; 2016 Aug; 17(8):914-21. PubMed ID: 27270401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
